Renewed & Ready! Langen Biomed is poised to soar with you towards shared success!

Company History：

Langen Biomed, formerly known as Integrated Electronic Systems (Shanghai) Ltd. (IES), was founded in 2008 by Mr. Zhou Jijun and Mr. Tom Cole as the first Chinese subsidiary of the UK-based ITL Group. Following ITL Group's acquisition by another UK-listed company in 2018, a significant organizational restructuring initiated by the new parent company in August 2023 unexpectedly forced IES – despite its stable operations – to cease operations, culminating in the dissolution of this 15-year enterprise.

In 2024, the management team reestablished its presence through two strategic entities:

• Langen Trading (Shanghai) Co., Ltd. (Commercial operations)

• Langen Biomed (Shanghai) Limited(Manufacturing & R&D)

Both entities operate under the unified Langen Biomed brand, sharing identical corporate DNA while maintaining specialized divisions of labor. This dual-structure revitalization continues the corporate legacy while forging new frontiers in biomedical innovation.

Since its inception, Langen Biomed has maintained an unwavering commitment to the R&D, production, and distribution of life science analytical instruments, medical diagnostic equipment, and cost-effective consumables. Certified under the ISO 13485 Medical Device Quality Management System, we have continuously enhanced product quality and optimized manufacturing processes, garnering widespread recognition in global markets. Our journey reflects the steadfast trust of valued partners, amplified by the relentless dedication of the Langen Biomed team in advancing precision diagnostics.

New Environment · New Horizons

This relocation marks another pivotal milestone in Langen Biomed's evolution. Our new premises feature enhanced functionality, a spacious layout, and cutting-edge facilities, creating an ecosystem that propels operational efficiency and technological advancement. This optimized work environment empowers our team to drive productivity while bolstering our capabilities in product innovation and service excellence.

Moving forward, we are raising our benchmarks to deliver superior products and technical solutions for global clients, reaffirming our commitment to being the innovation accelerator in precision diagnostics.

Gratitude for Our Journey Together ● Co-Creating a Bright Future

The growth of Langen Biomed would not have been possible without the steadfast support of every client, partner, and employee. On the occasion of our relocation, we extend our sincerest gratitude to all friends who have consistently cared for and supported us! Standing at this new starting point, we remain committed to our core principles of "Innovation-driven, customer-oriented, teamwork, ethical integrity, continuous improvement." We will keep breaking new ground, elevating our capabilities, and contributing greater value to the life sciences field.